• Return to Headlines

Intersect Ent In is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (XENT , ITCI , RVNC , TBPH , CTLT )

By Nick Russo

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Intersect Ent In (NASDAQ:XENT ) ranks first with a gain of 6.32%; Intra-Cellular T (NASDAQ:ITCI ) ranks second with a gain of 3.55%; and Revance Therapeu (NASDAQ:RVNC ) ranks third with a gain of 2.11%.

Theravance B (NASDAQ:TBPH ) follows with a gain of 1.54% and Catalent Inc (NYSE:CTLT ) rounds out the top five with a gain of 0.74%.

SmarTrend recommended that subscribers consider buying shares of Revance Therapeu on January 10th, 2020 as our technology indicated a new Uptrend was in progress when shares hit $18.55. Since that recommendation, shares of Revance Therapeu have risen 30.5%. We continue to monitor Revance Therapeu for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance intersect ent in intra-cellular t revance therapeu theravance b catalent inc

Ticker(s): XENT ITCI RVNC TBPH CTLT